bf/NASDAQ:PTCT_icon.jpeg

NASDAQ:PTCT

PTC Therapeutics

  • Stock

49.52

−0.64%

1.35

USD last updated 13/08 01:59:42

Last Close

48.17

13/08 22:24

Market Cap

2.44B

Beta: 0.42

Volume Today

1.10M

Avg: 752.35K

PE Ratio

−2.94

PFCF: −5.51

OverviewFinancialsAPI

This will be loaded shortly.

Loading

This is also still loading.

This will be loaded shortly.

Loading

This is also still loading.

This will be loaded shortly.

Loading

This is also still loading.

    Description

    PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. Its portfolio pipeline includes commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focuses on the development of treatments fo...Show More

    Excel Tearsheet

    Earnings

    Earnings per Share (Estimate*)

    -3-2.5-2-1.5-1-0.50.52018-03-062019-10-292021-05-042023-02-212024-08-08

    Revenue (Estimate*)

    100M200M300M400M2018-03-062019-10-292021-05-042023-02-212024-08-08

    *Estimate based on analyst consensus